Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed May 17, 2013 · 10-Q · 47 days after period end · 0001062993-13-002655
| Metric | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|
| Net Income | -$106.10K | -$910.20K | -$1.97M |
| EPS Diluted | $0.00 | -$0.03 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 17, 2013 · 47 d after period end
